In vivo priming of human mesenchymal stem cells with hepatocyte growth factor–engineered mesenchymal stem cells promotes therapeutic potential for cardiac repair

The clinical use of human bone marrow–derived mesenchymal stem cells (BM-MSCs) has been hampered by their poor performance after transplantation into failing hearts. Here, to improve the therapeutic potential of BM-MSCs, we developed a strategy termed in vivo priming in which BM-MSCs are primed in v...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sci Adv
Hlavní autoři: Park, Bong-Woo, Jung, Soo-Hyun, Das, Sanskrita, Lee, Soon Min, Park, Jae-Hyun, Kim, Hyeok, Hwang, Ji-Won, Lee, Sunghun, Kim, Hyo-Jin, Kim, Hey-Yon, Jung, Seungman, Cho, Dong-Woo, Jang, Jinah, Ban, Kiwon, Park, Hun-Jun
Médium: Artigo
Jazyk:Inglês
Vydáno: American Association for the Advancement of Science 2020
Témata:
Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7141892/
https://ncbi.nlm.nih.gov/pubmed/32284967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.aay6994
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky